Showing results (1-10 of 283) with videos related to
Sort By:
Pageof 29
Nihon Igaku Hoshasen Gakkai Zasshi. Nippon Acta Radiologica|April 16, 2003
[New trends in the diagnosis and treatment of malignant lymphoma]Kensei TobinaiCancer Chemotherapy and Pharmacology|June 24, 2003
Monoclonal antibodies for the treatment of hematologic malignancies: clinical trials in JapanKensei TobinaiSeminars in Hematology|April 3, 2010
Clinical trials for human T-cell lymphotropic virus type I-associated peripheral T-cell lymphoma in JapanKensei TobinaiNihon Rinsho. Japanese Journal of Clinical Medicine|March 22, 2002
[Rituximab, a chimeric mouse-human anti-CD20 monoclonal antibody]Kensei TobinaiInternal Medicine (Tokyo, Japan)|January 16, 2007
4. Antibody therapy for malignant lymphomaKensei Tobinai[Rinsho Ketsueki] the Japanese Journal of Clinical Hematology|September 8, 2016
Disease-oriented treatment of T/NK-cell lymphomasKensei TobinaiOncology (Williston Park, N.Y.)|February 4, 2010
Current management of adult T-cell leukemia/lymphomaKensei TobinaiNihon Rinsho. Japanese Journal of Clinical Medicine|January 26, 2002
[Treatment of B-cell lymphoma with a chimeric anti-CD20 monoclonal antibody(rituximab)]Kensei TobinaiInternational Journal of Clinical Oncology|September 5, 2003
Rituximab and other emerging antibodies as molecular target-based therapy of lymphomaKensei TobinaiPageof 29